Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

被引:7
作者
Herviou, Laurie [1 ]
Kassambara, Alboukadel [2 ]
Boireau, Stephanie [3 ]
Robert, Nicolas [3 ]
Requirand, Guilhem [3 ]
Vincent, Laure [4 ]
Seckinger, Anja [5 ,6 ]
Goldschmidt, Hartmut [7 ]
Hose, Dirk [5 ]
Cavalli, Giacomo [1 ]
Moreaux, Jerome [1 ,8 ]
机构
[1] CNRS UPR 1142, Inst Human Genet, Montpellier, France
[2] Univ Hosp Montpellier, CNRS UPR1142, Inst Human Genet, Montpellier, France
[3] Univ Hosp Montpellier, Montpellier, France
[4] CHU Montpellier, Dept Clin Haematol, Montpellier, France
[5] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[6] Heidelberg Univ, Dept Internal Med, Hematol Oncol, Heidelberg, Germany
[7] Heidelberg Univ, Dept Med 5, Heidelberg, Germany
[8] Univ Hosp Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France
关键词
D O I
10.1182/blood.V128.22.311.311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
311
引用
收藏
页数:4
相关论文
empty
未找到相关数据